ARCHIVES

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

This article is from The Cancer Letter archive.

Vol. 14 No. 41 | October 21, 1988

Download PDF Visit The Full Archive

Related Articles

Federal AIDS Funds Tp $2 Bil.; Term Proposed For NIH Director

October 19, 1990

DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each

June 11, 1982

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981

DCPC advisors OK 16 Year Trial Of Screening Methods

February 15, 1991

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

In Brief: GAO Studying Cancer Program So Congress Will Have Own Data; NCI Job Freeze Still Hurts Program

February 21, 1975